Your session is about to expire
← Back to Search
ICT Cell Therapy for Ovarian Cancer
Study Summary
This trial is testing a new medication to find a safe dose to use in further studies. Up to 12 people will be involved in each group.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have an autoimmune disease that needs strong medication to control.I have a serious fluid buildup around my heart.I have brain metastasis that has not been treated.My cancer is a type of advanced ovarian, fallopian tube, or peritoneal cancer that is resistant to platinum-based chemotherapy.I've had 2-3 treatments for my cancer, including platinum and PARP inhibitor if BRCA1/2 positive.I am fully active or can carry out light work.I have moderate to severe heart condition limitations.I needed fluid drained from my chest or abdomen for symptom relief within the last 28 days.I haven't had chemotherapy in the last 14 days.You have a disease that can be measured or evaluated according to the study's rules when you join the trial.My cancer worsened within 6 months of platinum treatment or my CA-125 levels doubled.Women who could become pregnant need to have a negative pregnancy test.My organs are functioning well.
- Group 1: AB-1015
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there still slots available for those wishing to participate in this experiment?
"Affirmative. Clinicaltrials.gov displays that this research endeavour, initially posted on November 1st 2022, is currently recruiting volunteers. Approximately 60 subjects need to be signed up from a single site."
Has AB-1015 been sanctioned by the FDA?
"Our team at Power gave AB-1015 a score of 1 since it is only in its first phase, thus there is limited evidence for safety and efficacy."
What is the current intake of participants for this research endeavor?
"Affirmative, the clinical trial is actively recruiting as per data available on clinicaltrials.gov. This research project was originally published on November 1st 2022 and modified most recently on November 18th 2022. Presently, 60 participants are needed to be recruited from a single medical centre."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- UCSF Helen Diller Family Comprehensive Cancer Center: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger